Diagnostic Automation / Cortez Diagnostics

What Diagnostic Automation / Cortez Diagnostics does

Diagnostic Automation / Cortez Diagnostics, Inc. (DACD) is a privately held diagnostic test kit manufacturer founded in 1989 and headquartered in Woodland Hills, California. The company designs and produces immunoassay-based diagnostic kits across six technology platforms — ELISA, Rapid Test, Immunofluorescence Assay (IFA), Chemiluminescence Immunoassay (CLIA), Serology, and supporting laboratory instruments (microplate readers/washers, incubator/shakers, rapid test readers, urine strip readers). Its catalog covers approximately 15 disease areas including allergy, autoimmune disease, infectious disease, cancer/tumor markers, cardiac markers, diabetes, fertility, thyroid, bone metabolism, and drug screening, with branded rapid drug test lines (RapiCard™, RapiDip™, RapiCup™).

The company monetizes through one-time hardware sales of test kits and instruments to four primary buyer segments — research laboratories, hospital laboratories, clinical laboratories, and physician practices — under a quote-based B2B pricing model. Distribution is executed through a hybrid go-to-market: a direct e-commerce storefront at rapidtest.com (built on Shift4Shop) for SMB and long-tail buyers, and a network of third-party distributors reaching customers across 168 countries globally. There is no indication of subscription, reagent-rental, or service-based recurring revenue.

Operationally, DACD presents as a long-tenured, founder-controlled niche manufacturer with broad product breadth but limited disclosed scale signals: no public revenue, headcount, institutional funding rounds, M&A activity, AI/ML capabilities, or named enterprise customers are reported in available source material. Its stated competitive positioning rests on product breadth, competitive pricing, fast shipping, and 35 years of operating history.

Name

Diagnostic Automation / Cortez Diagnostics

Legal name

DIAGNOSTIC AUTOMATION / CORTEZ DIAGNOSTICS, INC.

Website

https://diagnosticautomationinc.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Short description

Diagnostic Automation / Cortez Diagnostics is a privately held California-based manufacturer, founded 1989, that designs and sells ELISA, rapid test, CLIA, IFA, and serology diagnostic kits plus laboratory instruments to research labs, hospitals, clinical labs, and physicians across 168 countries.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Diagnostic test kits
• Immunoassay products
• ELISA test kits
• Rapid diagnostic tests
• Clinical laboratory supplies

Headquarters

HQ city

Woodland Hills

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Diagnostic Test Kit Sales: Sale of ELISA kits, Rapid Test kits, CLIA kits, Serology tests, and IFA kits for various diagnostic applications. Products are sold directly to research labs, hospitals, clinical labs, and physicians. One-time product sales with recurring customer relationships.
2. Diagnostic Instruments Sales: Sale of laboratory instruments including Incubator/Shaker, Microplate Reader, Microplate Washer, Rapid Test Reader, and Urine Strip Reader to support diagnostic testing operations.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Core offering

Diagnostic Automation / Cortez Diagnostics (DACD) manufactures and sells in-vitro diagnostic test kits, including ELISA kits, Rapid Test kits, CLIA (Chemiluminescence Immunoassay) kits, IFA (Immunofluorescence Assay) kits, and Serology tests, along with supporting laboratory instruments such as microplate readers, washers, incubators/shakers, rapid test readers, and urine strip readers. Products cover allergy, autoimmune diseases, infectious diseases, cancer/tumor markers, cardiac markers, diabetes, fertility, thyroid, bone metabolism, steroids, inflammatory markers, drug and alcohol detection, and women's health testing. The kits are sold to research labs, hospitals, clinical labs, and physicians across 168 countries through direct e-commerce at rapidtest.com and through distribution partners.

Product overview

Diagnostic Automation / Cortez Diagnostics (DACD) is a diagnostic test kit manufacturer founded in 1989, offering a comprehensive portfolio of diagnostic products that includes ELISA Kits, Rapid Test Kits (featuring RapiCard™ and RapiDip™ multi-drug tests and RapiCup™ panels), IFA (Immunofluorescence Assay) Kits, CLIA (Chemiluminescence Immunoassay) Kits, Serology Tests, and supporting Instruments. The company serves research labs, hospitals, clinical labs, and physicians across 168 countries, providing testing solutions for allergy, autoimmune diseases, infectious diseases, cancer/tumor markers, cardiac markers, diabetes, fertility, thyroid conditions, bone metabolism, and more. The product portfolio is organized into distinct testing technologies (ELISA, Rapid, IFA, CLIA, Serology) with specialized subcategories and supporting laboratory instruments.

Differentiator

Problem solved

Functional benefit

Products and services

• ELISA Kits

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Emerging players

• Artron Laboratories: Mid-sized Canadian IVD manufacturer with ELISA, rapid test, and serology kits sold globally — closely comparable to DACD in scale, technology menu, and reliance on export markets.
• Eagle Biosciences: US-based niche IVD reagent distributor/manufacturer supplying ELISA and immunoassay kits across endocrinology, infectious disease, and biomarkers — overlapping with the disease-area breadth of DACD's catalog.
• Wondfo: China-headquartered rapid diagnostics manufacturer with global distribution of lateral flow and immunoassay kits in infectious disease, drug testing, and women's health — comparable to DACD in rapid-test emphasis and emerging-market reach.

Direct peers

• EKF Diagnostics: Smaller publicly listed IVD company selling immunoassay, ELISA, and rapid test kits for fertility, cardiac markers, infectious disease, and diabetes to clinical and research labs, with comparable breadth to DACD.
• Creative Diagnostics: Privately held IVD reagent manufacturer offering ELISA, lateral flow rapid tests, CLIA, IFA, and serology kits to labs worldwide — closest head-to-head peer to DACD in product mix, customer base, and e-commerce-led distribution.
• Bio-Rad Laboratories: Direct peer in IVD reagents and immunoassays with a long-standing ELISA, serology, and quality-control kit portfolio sold globally to research and clinical labs — overlapping almost category-for-category with DACD's product set.
• QuidelOrtho: Specialized diagnostics company whose Triage, Sofia, and Vitros lines span rapid immunoassays, ELISA, and serology — directly competitive with DACD's cardiology, infectious disease, and pregnancy/fertility rapid tests.

Broad incumbents

• Roche Diagnostics: Largest global IVD incumbent with cobas/e601 immunoassay, Elecsys serology, and rapid test lines; defines the automated-workflow standard against which DACD positions its ELISA/IFA/rapid/serology kits.
• Siemens Healthineers: Major IVD incumbent with Atellica/ADVIA Centaur immunoassay, CLIA, and infectious disease serology menus — competes with DACD in chemistry, cardiac, and infectious-disease categories across hospital customers.
• Abbott Diagnostics: Global IVD incumbent offering Architect/Alinity immunoassay, rapid, and serology menus that overlap DACD's disease categories; sets pricing and menu standards DACD must compete against in hospital and reference-lab tenders.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/dacd_inc
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/diagnostic-automation-cortez-diagnostics-inc.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnostic Automation / Cortez Diagnostics